Journal of Hematology & Oncology · 2014 · 46 citations · 40 references
MedicineCancer BiologyCell BiologyMolecular OncologyStem Cell BiologyTumor ProgressionArsenic ToxicologyCancer Cell SignalingCancer ProgressionCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsAcute Promyelocytic LeukemiaCd133 ExpressionDifferentiationSelf-renewalSelf-renewal RegulationStemness RegulationTerminal Differentiation ArrestXenograft Survival
BACKGROUND: Cancer stem cells (CSCs) play a key role in the posthepatectomy recurrence of hepatocellular carcinoma (HCC). CD133+ HCC cells exhibit liver CSC-like properties, and CSC differentiation-inducing therapy may lead these cells to lose their self-renewal ability and may induce terminal differentiation, which may in turn allow their malignant potential to be controlled. Because arsenic trioxide (As₂O₃) increases remission rates and prolongs survival among patients with acute promyelocytic leukemia by inducing differentiation and apoptosis of leukemic cells, we hypothesized that As₂O₃ might also inhibit HCC recurrence and prolong survival time after hepatectomy by inducing differentiation of HCC CSCs. METHODS: We evaluated the As₂O₃ induced differentiation of human HCC CSCs and its mechanism in vitro, and we investigated the effects of treatment with As₂O₃ on recurrence rates and median survival in a mouse xenograft model. RESULTS: We found that As₂O₃ induced HCC CSC differentiation by down-regulating the expression of CD133 and some stemness genes, thus inhibiting the cells' self-renewal ability and tumorigenic capacity without inhibiting their proliferation in vitro. In vivo experiments indicated that As₂O₃ decreased recurrence rates after radical resection and prolonged survival in a mouse model. As₂O₃, which shows no apparent toxicity, may induce HCC CSC differentiation by down-regulating the expression of GLI1. CONCLUSIONS: We found that As₂O₃ induced HCC CSC differentiation, inhibited recurrence, and prolonged survival after hepatectomy by targeting GLI1expression. Our results suggest that the clinical safety and utility of As₂O₃ should be further evaluated.
40
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Identification of cells initiating human melanomas
Tobias Schatton, Gëorge F. Murphy, Natasha Y. Frank et al. · Nature · 2008 · 1.4K citations
Medicine, Cancer Biology, Oncology +12
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Stephanie Ma, Kwok‐Wah Chan, Liang Hu et al. · Gastroenterology · 2007 · 1.2K citations · Full text
Medicine, Cancer Biology, Oncology +12
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
Daniel D. Von Hoff, Patricia LoRusso, Charles M. Rudin et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17